SCHEMBL20165895

SCHEMBL20165895

N#Cc1cccc(-c2ccncc2)c1C#N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.45
GSK3B P49841 2/20 0.45
HTT P42858 1/20 0.43
SQOR Q9Y6N5 1/20 0.43
CYP2C19 P33261 2/20 0.43
PDE3B Q13370 2/20 0.43
PDE3A Q14432 2/20 0.43
KDM4E B2RXH2 2/20 0.43
PDE5A O76074 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
PTGS1 P23219 1/20 0.43
PDE4A P27815 1/20 0.43
BLM P54132 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
PDE10A Q9Y233 1/20 0.43
ADORA1 P30542 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL820505 0.86 ESR2 (0.48) SQORCYP2C19KDM4EHPGDTSHR
SCHEMBL31663604 0.83 ADORA1 (0.56) HTTSQORCYP2C19KDM4ETSHR
SCHEMBL30359283 0.82 SMN1; SMN2 (0.51) SQORCYP2C19KDM4EHPGDTSHR
SCHEMBL769515 0.82 SMN1; SMN2 (0.51) SQORCYP2C19KDM4EHPGDTSHR
SCHEMBL3224025 0.82 ESR2 (0.60) GSK3AGSK3BHTTSQORCYP2C19
SCHEMBL31663514 0.82 ESR2 (0.60) GSK3AGSK3BHTTSQORCYP2C19
Methane SCHEMBL28932814 0.81 SMN1; SMN2 (0.50) SQORCYP2C19KDM4EHPGDTSHR
SCHEMBL28721464 0.81 KDM4E (0.50) HTTKDM4ELMNAHPGDTSHR
SCHEMBL1423587 0.80 ESR2 (0.49) GSK3AGSK3BHTTCYP2C19PDE3B
SCHEMBL2657692 0.80 HTT (0.42) GSK3AGSK3BHTTSQORCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109996801-B Photosensitizers 等离子体光学有限公司 2022-03-22 CN claimed
US-10875871-B2 Photosensitizer Tampereen Korkeakoulusäätiö SR (FI) 2020-12-29 US claimed
US-20190337958-A1 PHOTOSENSITIZER PUNDA GLOBAL OY (FI) 2019-11-07 US claimed
EP-3541818-A1 PHOTOSENSITIZER Tampereen Korkeakoulusäätiö SR (FI) 2019-09-25 EP claimed
WO-2018091774-A1 PHOTOSENSITIZER TTY-SÄÄTIÖ (FI) 2018-05-24 WO claimed
CN-109996801-B Photosensitizers 等离子体光学有限公司 2022-03-22 CN disclosed
US-10875871-B2 Photosensitizer Tampereen Korkeakoulusäätiö SR (FI) 2020-12-29 US disclosed
US-10875871-B2 Photosensitizer Tampereen Korkeakoulusäätiö SR (FI) 2020-12-29 US disclosed
US-20190337958-A1 PHOTOSENSITIZER PUNDA GLOBAL OY (FI) 2019-11-07 US disclosed
EP-3541818-A1 PHOTOSENSITIZER Tampereen Korkeakoulusäätiö SR (FI) 2019-09-25 EP disclosed
WO-2018091774-A1 PHOTOSENSITIZER TTY-SÄÄTIÖ (FI) 2018-05-24 WO disclosed
WO-2018091774-A1 PHOTOSENSITIZER TTY-SÄÄTIÖ (FI) 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190337958-A1 PHOTOSENSITIZER PPOX, GPX4, LPO GSK3A 4411/4885GSK3B 4609/4885HTT 1955/4885
US-10875871-B2 Photosensitizer PPOX, GPX4, LPO GSK3A 4411/4885GSK3B 4609/4885HTT 1955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.